Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry
- 1 May 1996
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 100 (5) , 530-536
- https://doi.org/10.1016/s0002-9343(96)00060-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Anticardiolipin antibodies in an unselected stroke populationThe Lancet, 1994
- Assays for Detection of Antiphospholipid AntibodiesLupus, 1994
- Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.Annals of the Rheumatic Diseases, 1993
- The antiphospholipid syndrome: ten years onThe Lancet, 1993
- Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic strokeThe Lancet, 1992
- Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia.Stroke, 1992
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural PatternsBritish Journal of Haematology, 1978